Xifaxan and Augmentin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xifaxan (rifaximin) and Augmentin (amoxicillin; clavulanate potassium). Common drug interactions include deafness among females and memory impairment among males.

The phase IV clinical study analyzes what interactions people have when they take Xifaxan and Augmentin. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Xifaxan?

Xifaxan has active ingredients of rifaximin. It is often used in irritable bowel syndrome. eHealthMe is studying from 16,609 Xifaxan users. Check the latest studies of Xifaxan.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.



On Jul, 13, 2026

32 people who take Xifaxan and Augmentin together, and have interactions are studied.

Xifaxan and Augmentin drug interactions.

What are the common drug interactions of Xifaxan and Augmentin, by gender? *:

female:

  1. Deafness
  2. Dental care
  3. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  4. Diabetic gastroparesis (paralysis of the muscles of the stomach caused by diabetes)
  5. Drug ineffective
  6. Dry mouth
  7. Flushing (the warm, red condition of human skin)
  8. Gait disturbance
  9. Gingival ulceration (ulcer on gums)
  10. Heart rate decreased

male:

  1. Memory impairment
  2. Abdominal pain
  3. Coagulopathy (blood's ability to clot is impaired)
  4. Confusional state
  5. Dizziness
  6. Epistaxis (bleed from the nose)
  7. Fluid overload (too much fluid in the blood)
  8. Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
  9. Haematemesis (vomiting of blood)
  10. Haemoglobin decreased

What are the common drug interactions of Xifaxan and Augmentin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain upper
  2. Dyspnoea (difficult or laboured respiration)
  3. Headache (pain in head)
  4. Migraine (headache)
  5. Nausea (feeling of having an urge to vomit)
  6. Urticaria (rash of round, red welts on the skin that itch intensely)
  7. Blood glucose decreased
  8. Blood pressure decreased
  9. Blood pressure increased
  10. Heart rate decreased

30-39:

n/a

40-49:

  1. Haemoglobin decreased
  2. Hypersplenism (enlarged spleen and a decrease in one or more types of blood cells)
  3. Hypotension (abnormally low blood pressure)
  4. Liver transplant
  5. Memory impairment
  6. Muscle spasms (muscle contraction)
  7. Nausea (feeling of having an urge to vomit)
  8. Nodule (a growth of abnormal tissue)
  9. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  10. Pericardial effusion (fluid around the heart)

50-59:

  1. Ear infection
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Chronic kidney disease
  4. Renal failure (kidney dysfunction)

60+:

  1. Back pain
  2. Pneumonia
  3. Fatigue (feeling of tiredness)
  4. Flatulence (flatus expelled through the anus)
  5. Gait disturbance
  6. Hospitalisation
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Pruritus (severe itching of the skin)
  9. Rash
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 4 people, 12.50%
  2. Immunodeficiency Common Variable: 4 people, 12.50%
  3. Pulmonary Hypertension (increase in blood pressure in the lung artery): 3 people, 9.38%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 9.38%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 9.38%
  6. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 6.25%
  7. Pain: 2 people, 6.25%
  8. Itching: 2 people, 6.25%
  9. High Blood Pressure: 2 people, 6.25%
  10. Hepatocellular Carcinoma (liver cancer): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Xifaxan and Augmentin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Xifaxan and Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xifaxan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xifaxan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rifaximin and amoxicillin; clavulanate potassium (the active ingredients of Xifaxan and Augmentin, respectively), and Xifaxan and Augmentin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: